380) nfinity were within 0.75- to 1.25-fold of observed values in healthy adults receivin |
381) d clearances (CLs) were compared with the observed values. |
382) decrease in absolute and relative BM was observed (0.70 ± 0.4 kg, p < 0.05 & |
383) nificant heterogeneity across studies was observed (P = 0.383; I2 = 5.8%). |
384) within-group functional differences were observed (SRT-Early Sounds vs. |
385) hes and injuries for some road users were observed (e.g., car occupants). |
386) Grade 3 treatment-related adverse events observed (hypersensitivity and diarrhea). |
387) niches in which this relationship can be observed - we would like to challenge some |
388) We observed 13 additional rare variants in 18 |
389) , particularly African Americans, with an observed 2-fold higher rate for hospitaliz |
390) The most commonly observed ARB were E. |
391) The predicted/observed CLsec, CLrenal, and CLtotal of dr |
392) lar epithelial characteristics (A549), we observed CSE-mediated downregulation of FO |
393) ene metabolite may be responsible for the observed CYP3A inactivation. |
394) t, habitual, and maximalist footwear were observed During a self-paced run. |
395) s widespread, the drivers influencing the observed ESBL-E. |
396) ductions performed better compared to the observed PM2.5. |
397) However, the variation of observed PNCs and particle size distributi |
398) ures, rotation frequencies, and variables observed.Conclusions: There is a rapid gro |
399) Administering DOT (Directly Observed Treatment) to the patient was the |
400) S inhibitor N-acetyl-L-cysteine (NAC), we observed abrogated mRNA expression of seve |
401) We observed accumulation of nuclear debris in |
402) Orderly log b and log d values have been observed across diverse clinical populatio |
403) e preliminarily concluded that the lowest observed adverse effect level (LOAEL) of a |
404) blood exposure to [18F]ciprofloxacin was observed along with a significant reductio |
405) how male adolescents who had experienced, observed, and/or initiated abuse were at i |
406) m FTLD-Tau patients demonstrates ONL loss observed antemortem on OCT. |
407) tion on ear keloid surface, hemolysis was observed around the dominant bacteria afte |
408) coadministration with rifampicin could be observed: atorvastatin (AUC ratio 7.2) > |
409) -trial imbalances in the distributions of observed baseline covariates between the t |
410) w that this new approach corrects for the observed bias. |
411) osuvastatin was found to be closer to the observed biliary clearance. |
412) e may also have a significant role in the observed biomarker variability following i |
|